Bonraybio Co., Ltd. (TPE:6955)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
162.00
+2.50 (1.57%)
At close: Jan 21, 2026
29.38%
Market Cap4.02B
Revenue (ttm)287.10M
Net Income (ttm)96.28M
Shares Out24.80M
EPS (ttm)3.92
PE Ratio41.31
Forward PEn/a
Dividend1.30 (0.82%)
Ex-Dividend DateMar 27, 2025
Volume9,000
Average Volume7,819
Open160.00
Previous Close159.50
Day's Range159.50 - 162.00
52-Week Range104.35 - 186.96
Beta-0.19
RSI57.52
Earnings DateFeb 26, 2026

About Bonraybio

Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also offers consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded... [Read more]

Sector Healthcare
Founded 2015
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6955
Full Company Profile

Financial Performance

In 2024, Bonraybio's revenue was 222.88 million, an increase of 39.61% compared to the previous year's 159.64 million. Earnings were 68.37 million, an increase of 165.75%.

Financial Statements